Related Experiment Video

Updated: Aug 8, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Remission of chronic inflammatory demyelinating polyneuropathy after alemtuzumab (Campath 1H)

C Hirst, S Raasch, G Llewelyn

    Journal of Neurology, Neurosurgery, and Psychiatry
    |May 18, 2006
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Concept Videos